The Joint DIA FIP European Workshop Biorelevant Performance Testing of Orally Administered Dosage Forms 2014 is dedicated to
- Biorelevant in vitro Performance Tests
- Challenges in Simulating the Changing GI Environment for the Evaluation of Dosage Form Performance
- Evaluation of Supersaturating Drug Delivery Systems
- Evaluation of Lipid Dosage Forms
- Gastrointestinal Physiology and in vitro Simulation
- Luminal Hydrodynamics and in vitro Simulation
- Luminal Composition and in vitro Simulation
- Oral Biopharmaceutics Tools: A European academic-industy consortium
- Biorelevant in vitro Performance Tests: Definitions and current issues
- Looking at the Regulators
- Biorelevance versus Quality Control: Separate or bridge?
- PBPK Modeling of Oral Drug Absorption
- PBPK Modeling of Oral Drug Absorption Using SimSyp
- PBPK Modeling of Oral Drug Absorption Using PK-Sim
- PBPK Modeling of Oral Drug Absorption Using GastroPlus
The Joint DIA FIP European Workshop Biorelevant Performance Testing of Orally Administered Dosage Forms 2014 is intended for Scientists from industry, academia and regulatory agencies, including graduate students with a primary interest in development of orally administered drug products.
